Smith & Nephew SNATS (NYSE:SNN) Sees Large Volume Increase – Time to Buy?

Posted by Brenda Bartman on Jul 18th, 2026

Smith & Nephew SNATS, Inc. (NYSE:SNN – Get Free Report) shares saw unusually-high trading volume on Thursday . 1,714,084 shares traded hands during trading, an increase of 54% from the previous session’s volume of 1,114,004 shares.The stock last traded at $31.4450 and had previously closed at $30.80.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on SNN shares. The Goldman Sachs Group reissued a “buy” rating on shares of Smith & Nephew SNATS in a research note on Monday, May 25th. Canaccord Genuity Group lowered their price objective on shares of Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating for the company in a research report on Monday, May 11th. Wall Street Zen upgraded shares of Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Weiss Ratings lowered Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, June 11th. Finally, Kepler Capital Markets cut Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research note on Thursday, June 4th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Smith & Nephew SNATS has a consensus rating of “Hold” and an average price target of $30.93.

Check Out Our Latest Stock Report on Smith & Nephew SNATS

Smith & Nephew SNATS Price Performance

The company has a debt-to-equity ratio of 0.60, a current ratio of 2.57 and a quick ratio of 1.25. The firm has a 50-day simple moving average of $30.23 and a two-hundred day simple moving average of $32.36.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Garner Asset Management Corp acquired a new stake in Smith & Nephew SNATS during the 4th quarter worth approximately $27,000. Arax Advisory Partners grew its stake in shares of Smith & Nephew SNATS by 142.6% in the fourth quarter. Arax Advisory Partners now owns 968 shares of the medical equipment provider’s stock worth $32,000 after acquiring an additional 569 shares in the last quarter. Advisors Asset Management Inc. acquired a new position in shares of Smith & Nephew SNATS in the fourth quarter worth $36,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Smith & Nephew SNATS during the third quarter worth $41,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Smith & Nephew SNATS during the fourth quarter worth $43,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew SNATS Company Profile

(Get Free Report)

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.